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harakiri, a novel regulator of cell death, encodes a
protein that activates apoptosis and interacts
selectively with survival-promoting proteins Bcl-2
and Bcl-XL
White, 1996). Several regulatory components of the apop-Naohiro Inohara, Liyun Ding, Shu Chen and
totic pathway have been identified in various living organ-Gabriel Núñez1
isms including man (Thompson, 1995; White, 1996).
Department of Pathology and Comprehensive Cancer Center, bcl-2, the first member of an evolutionarily conserved
The University of Michigan Medical School, Ann Arbor, MI 48109, family of apoptosis regulatory genes, was isolated initially
USA
from the t(14;18) chromosomal translocation found in
1Corresponding author human B-cell follicular lymphomas and subsequently was
shown to repress cell death triggered by a diverse array
Programmed cell death is essential in organ develop- of stimuli (Vaux et al., 1988; Núñez et al., 1990; Strasser
ment and tissue homeostasis and its deregulation is et al., 1991). Several members of the family including
associated with the development of several diseases in Bcl-2, Bcl-XL, Mcl-1, A1, Bcl-w and Ced-9 share con-mice and humans. The precise mechanisms that control served regions termed Bcl-2 homology domain 1, 2, 3
cell death have not been elucidated fully, but it is well and 4 (BH1, BH2, BH3 and BH4) and function by
established that this form of cellular demise is regulated repressing apoptosis (for review, see White, 1996). In
by a genetic program which is activated in the dying contrast, other members of the family, such as Bax and
cell. Here we report the identification, cloning and Bak, share BH1, BH2 and BH3 domains and regulate
characterization of harakiri, a novel gene that regulates apoptosis by promoting cell death at least in part through
apoptosis. The product of harakiri, Hrk, physically physical interactions with death-repressing Bcl-2 family
interacts with the death-repressor proteins Bcl-2 and members (Oltvai and Korsmeyer, 1994; Sato et al., 1994).
Bcl-XL, but not with death-promoting homologs, Bax Two members of the family, Bcl-2 and Bcl-XL, areor Bak. Hrk lacks conserved BH1 and BH2 regions expressed in many embryonic and adult tissues, and their
and significant homology to Bcl-2 family members or
importance has been revealed by analysis of mutant mice
any other protein, except for a stretch of eight amino
deficient in Bcl-2 or Bcl-XL. Null mutations of bcl-x areacids that exhibits high homology with BH3 regions.
embryonic lethal with the occurrence of profound cell
Expression of Hrk induces cell death which is inhibited
death, whereas mice deficient in bcl-2 die early after birth
by Bcl-2 and Bcl-XL. Deletion of 16 amino acids (Veis et al., 1993; Motoyama et al., 1995). However, the
including the conserved BH3 region abolished the
biochemical process by which Bcl-2 and Bcl-XL repressability of Hrk to interact with Bcl-2 and Bcl-XL in cell death and the mechanisms that regulate their functionsmammalian cells. Moreover, the killing activity of this
are poorly understood. The susceptibility of a cell tomutant form of Hrk (Hrk ΔBH3) was eliminated or
apoptotic signals appears to be regulated in part by thedramatically reduced, suggesting that Hrk activates
relative levels and competing dimerizations of differentcell death at least in part by interacting with and
Bcl-2 family members (Oltvai and Korsmeyer, 1994). Ininhibiting the protection afforded by Bcl-2 and Bcl-
addition to Bcl-2 family members, Bcl-2 is known toXL. Because Hrk lacks conserved BH1 and BH2 interact with several cellular proteins that include R-Ras,domains that define Bcl-2 family members, we propose
Nip proteins and BAG-1 which appear to be part of signalthat Hrk and Bik/Nbk, another BH3-containing protein
transduction pathways (Boyd et al., 1994; Fernandez-that activates apoptosis, represent a novel class of
Sarabia and Bischoff, 1994; Takayama et al., 1995; Wangproteins that regulate apoptosis by interacting select-
et al., 1996). However, the biochemical significance ofively with survival-promoting Bcl-2 and Bcl-XL. these Bcl-2 interactions is unclear and poorly understood.Keywords: apoptosis/Bcl-2 family/Hrk/programmed cell
Here we report the identification, cloning and character-death
ization of harakiri, a novel apoptosis regulatory gene. The
product of harakiri, Hrk, physically interacts with the
death-repressor proteins Bcl-2 and Bcl-XL, but not with
death-promoting Bax or Bak. Hrk lacks conserved BH1
Introduction
and BH2 regions and significant homology to Bcl-2 family
members or any other protein, except for a stretch of eightApoptosis, a morphologically distinguished form of pro-
amino acids that exhibits high homology with BH3 regions.grammed cell death, is critical not only during development
Hrk structurally resembles Bik/Nbk, another BH3-con-and tissue homeostasis but also in the pathogenesis of a
taining protein which was identified recently as an inter-variety of diseases including cancer, autoimmune disease,
acting partner of the adenovirus E1B 19K protein andviral infection and neurodegenerative disorders (Thomp-
Bcl-2 (Boyd et al., 1995; Han et al., 1996b). Beyond theson, 1995). The precise mechanisms that regulate apoptosis
conserved BH3 region, however, Bik/Nbk and Hrk do nothave not been elucidated; however, it appears that this
share any significant amino acid homology. Expression ofform of cell death is controlled by a genetic program
which is activated in the dying cell (Thompson, 1995; Hrk induced cell death which was repressed by Bcl-2 and
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Bcl-XL. Deletion of the conserved BH3 region in Hrk
abolished its ability to interact with Bcl-2 and Bcl-XL,
and dramatically diminished its killing activity when
compared with wild-type Hrk. Because Hrk lacks con-
served BH1 and BH2 domains that define Bcl-2 family
members, we propose that Bik/Nbk and Hrk represent a
novel class of proteins that regulate apoptosis at least in
part by interacting selectively with survival-promoting
Bcl-2 and Bcl-XL.
Results
Two-hybrid screening for proteins that bind to
Bcl-2 reveals a novel protein that interacts with
anti-apoptosis proteins Bcl-2 and Bcl-XL but not Fig. 1. Specificity of the interaction between Hrk and Bcl-2 family
with death-promoting proteins Bax and Bak
members in yeast. A plasmid expressing Hrk fused to the GAL4
To search for Bcl-2-interacting proteins, we screened a DNA-binding domain was co-transfected with plasmids expressing
HeLa cDNA library using GAL4–Bcl-2 as a ‘bait’ in the Bcl-2 family members fused to the GAL4 transcriptional activation
domain (AD). Growth of yeast in the absence of leucine, tryptophanyeast two-hybrid assay. In a screen of 3106 library
and histidine is indicative of protein–protein interaction. Growth in theclones, 30 positive clones were identified that interacted
absence of leucine and tryptophan is shown as a control.
with the GAL4–Bcl-2 bait. Plasmids recovered from the
original yeast strain were used in a co-transformation assay
with the original GAL4–Bcl-2 bait or control heterologous
baits to discard false-positive clones. Twenty one cDNAs
control plasmid. In these initial experiments, the entire
(designated BP1–21) were found to contain inserts of harakiri sequence that was fused to the GAL4 DNA-
different sizes (from 1.3 to 0.7 kb) that interacted with
binding domain was cloned into expression plasmids
the GAL4–Bcl-2 bait but not with control baits. These
to produce Flag-Hrk. Immunoprecipitates were prepared
cDNA clones were characterized by restriction enzyme
using hamster anti-Bcl-2 monoclonal antibody and sub-
mapping and nucleotide sequence analysis. As expected,
jected to SDS–PAGE and immunoblotting using anti-
multiple clones encoded proteins which are known to
Flag or Bcl-2 antibody. Immunoblotting with anti-Bcl-2
associate with Bcl-2 in mammalian cells. Seven cDNAs
antibody revealed that Flag-Hrk was co-immunoprecipi-encoded Bad, three encoded Bax and two encoded Bik/
tated with Bcl-2 (Figure 2A). Control immunoblottingNbk (Oltvai et al., 1993; Boyd et al., 1995; Yang et al.,
with anti-Bcl-2 antibody confirmed that Bcl-2 was1995; Han et al., 1996b). Four cDNAs encoded a Ras-
immunoprecipitated in lysates of cells transfected with therelated protein (Yamagata et al., 1994). The two-hybrid
bcl-2 plasmid (Figure 2A). The Hrk–Bcl-2 interaction wasscreen also yielded five cDNA clones with novel nucleotide
specific in that it required co-expression of both Bcl-2sequences. Restriction enzyme and sequence analysis
and Flag-Hrk, and was not detected when the lysate wasrevealed that four of the novel positive clones contained
immunoprecipitated with control antibody (Figure 2A).identical inserts of 712 bp fused to the GAL4 DNA-
To verify the interaction, we performed reciprocal experi-binding domain. One of these four cDNA clones was
ments using anti-Flag antibody to immunoprecipitate Flag-characterized further. We have named this novel gene
Hrk, followed by Western blot with anti-Bcl-2 antibody.‘harakiri’ and the product that it encodes Hrk, after the
In agreement with the reverse experiment, Bcl-2 co-Japanese suicide ritual (see below).
immunoprecipitated specifically with Flag-Hrk (FigureTo characterize the specificity of the Hrk interactions
2B).further, we determined the ability of Hrk to interact with
To determine if Hrk associates with Bcl-XL in mamma-Bax, Bak and Bcl-XS, three Bcl-2-related proteins that
lian cells, we performed immunoprecipitation experimentspromote cell death. In the yeast two-hybrid system, Hrk
similar to those performed to assess the Hrk–Bcl-2 inter-interacted with Bcl-2 and Bcl-XL but not with Bax, Bak
action. After transfection of 293T cells with expressionor Bcl-XS (Figure 1). These results indicate that Hrk
plasmids producing a Flag-tagged Hrk protein and Bcl-selectively interacts with Bcl-2 family members such as
XL or control plasmid, immunoprecipitates were preparedBcl-2 and Bcl-XL which are functionally related in that
using anti-Bcl-X antibody and subjected to SDS–PAGEthey are capable of inhibiting apoptosis. Importantly, Hrk
immunoblotting using anti-Flag antibody. Importantly,failed to associate with Bcl-XS, an alternative form of
Flag-Hrk was co-immunoprecipitated specifically withBcl-X, that lacks an internal region of 62 amino acids
Bcl-XL (Figure 2C). To confirm the interaction, we per-that is required for Bcl-XL protective function (Boise
formed reciprocal experiments using anti-Flag antibodyet al., 1993).
to immunoprecipitate Flag-Hrk, followed by Western blot
with anti-Bcl-X antibody. In agreement with the reverseHrk interacts with Bcl-2 and Bcl-XL in mammalian
experiment, Bcl-XL co-immunoprecipitated specificallycells
with Flag-Hrk (Figure 2D). We also tested if Hrk interactsTo confirm that Hrk associates with Bcl-2 and Bcl-XL in
with Bax in 293T cells and found that Flag-Hrk failed tomammalian cells, a 293T human kidney cell line was
co-immunoprecipitate with Bax, confirming our results intransiently co-transfected with expression plasmids produ-
cing a Flag-tagged Hrk protein and Bcl-2, Bcl-XL or the yeast assay (data not shown).
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Fig. 2. Hrk interacts with Bcl-2 and Bcl-XL in mammalian cells. 293T cells (5106 per 100 mm plate) were transiently transfected with 10 μg of
the indicated plasmids, pSFFV-Flag-tagged BP25 (control), pSFFV-Flag-Hrk16K (Hrk), pSFFV-hBcl-2 (Bcl-2), pSFFV-HA-hBcl-XL (Bcl-XL) or
pSFFV-HA-mBax (Bax). In the case of transfection with a single plasmid, cells were co-transfected with 10 μg of empty pSFFV-neo vector and the
total amount of plasmid DNA was always 20 μg. (A) Lysates were immunoprecipitated with anti-Bcl-2 or control antibody. Immunoprecipitates were
immunoblotted with anti-Bcl-2 or anti-Flag antibody. (B) Anti-Flag or control antibody immunoprecipitates were immunoblotted with anti-Bcl-2
antibody. (C) Anti-Bcl-X or control antibody immunoprecipitates were immunoblotted with anti-Flag antibody. (D) Anti-Flag or control antibody
immunoprecipitates were immunoblotted with anti-Bcl-X antibody. Notice that pSFFV-Flag-Hrk16K produces 16 kDa protein. as the entire harakiri
cDNA including its 5 untranslated region was fused in-frame with the Flag sequence and the amino-terminus of Hrk.
harakiri encodes a novel protein with a conserved and predicted to be present in other Bcl-2 family members
(Figure 3C). A region of 28 hydrophobic residues thatBH3 region but lacking BH1 or BH2 domains
To confirm the sequence obtained by the two-hybrid assay, may serve as a membrane-spanning domain was identified
at the COOH-terminus of the Hrk coding region (Figurea 9-week embryo human cDNA library was screened by
hybridization with a labeled harakiri probe. Forty positive 3A).
cDNA clones were identified and characterized by restric-
tion mapping, PCR analysis and sequencing. Analysis of harakiri displays a highly restricted expression in
human tissuesthe longest cDNAs revealed inserts of 716 bp essentially
identical in sequence to that observed previously fused to To characterize harakiri further, its expression pattern was
examined by Northern blot analysis using a harakiri probethe GAL4 DNA-binding domain. A single nucleotide
difference C→T at position 334 of the harakiri cDNA of various RNA samples isolated from human adult tissues.
A major 0.7 kb transcript was detected in all lymphoidwas noted between the coding sequences obtained from
the HeLa and embryo cDNA libraries (Figure 3A). This tissues tested but was expressed predominantly in bone
marrow and spleen (Figure 4). Further analysis showednucleotide difference did not change the amino acid
sequence of Hrk, reflecting perhaps a gene polymorphism. that harakiri mRNA was also expressed in pancreas and
at very low or undetectable levels in kidney, liver, lungNorthern blot analysis of mouse and human tissues using
a labeled harakiri probe identified a major mRNA species and brain (data not shown).
of ~0.7 kb in certain tissues (see below). Taken together,
these results suggest that the isolated cDNA clones are The Flag-Hrk protein is a non-nuclear intracellular
proteinfull-length. The cDNAs encode an open reading frame of
91 amino acids (Figure 3A). In the 3 untranslated region, In order to begin to assess the subcellular localization of
Hrk, we transiently transfected a Flag-harakiri constructan ATTTA sequence motif for RNA destabilization (Shaw
and Kamen, 1986) and a poly(A) tail were identified. into 293 cells and determined the intracellular localization
of the Flag-Hrk protein by laser scanning confocal micro-Initial DNA searches using the NCBI BLAST program
revealed that the nucleotide sequence was novel in that scopy. Analysis of labeled cells with anti-Flag monoclonal
antibody revealed that Flag-Hrk displays a labeling patternthey did not reveal significant homology to any known
gene or translated products in the databases. However, which was granular and extranuclear, consistent with
a localization confined to membranes of intracellularclose inspection of the Hrk protein revealed a stretch of
eight amino acids, Hrk 37–44, with high homology to a organelles (Figure 5A). The labeling pattern of Hrk was
similar to that previously reported for Bcl-2 and Bcl-XL,BH3 motif. This conserved region is shared by Bcl-2
family members (Chittenden et al., 1995b; Zha et al., suggesting that Hrk, Bcl-2 and Bcl-XL localize to similar
intracellular compartments in mammalian cells (Krajewski1996). The BH3 region of Hrk was contained within a
predicted α-helix which has been described recently in et al., 1993; González-Garcı́a et al., 1994). The specificity
of the labeling was determined by assessing the stainingthe crystal structure of Bcl-XL (Muchmore et al., 1996),
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Fig. 4. Expression of harakiri mRNA by Northern blot analysis. A
filter loaded with 2 μg of poly(A) RNA from various tissues of the
immune system was hybridized with the entire harakiri cDNA probe
labeled with 32P, washed with 0.2 SSC at 65°C for 1 h. The filter
was exposed to X-ray film for 12 h. 28S rRNA, 18S rRNA and the
major transcript of 0.7 kb are indicated by arrowheads. PBL,
peripheral blood leukocytes.
cell survival (Figure 6A, C, E and G). Significantly,
co-expression of Bcl-2 or Bcl-XL inhibited the death-
Fig. 3. harakiri encodes a novel BH3-containing protein. (A) The promoting activity of Hrk (Figure 6D and H). To verify
nucleotide sequence of human harakiri cDNA. The sequence from the these results further, we performed additional experiments
longest cDNA clone isolated from a 9-week embryo is shown. The
in which Hrk plasmids were transfected into 293, HeLacoding region is indicated with its amino acid sequence. A conserved
and FL5.12 progenitor B cells. Transient transfection ofBH3 region and a putative transmembrane domain are indicated by
double and single underlining in the amino acid sequence, respectively. 293 and HeLa cells with Hrk plasmids induced cell death
An ATTTA sequence motif for RNA destabilization identified in the with kinetics similar to those observed with 293T cells
3 untranslated region is boxed. A putative nucleotide polymorphism (data not shown). To date, we have been unable to generate
was observed, C→T at position 334 of the cDNA, and is shown by
any stable FL5.12 cell lines that express transfected Hrkunderlining in the nucleotide sequence. (B) Schematic structure of
in the absence of exogenous Bcl-2 or Bcl-XL, suggestingHrk. (C) Comparison of the BH3 domains between Hrk and Bcl-2
family members. Identical and conserved hydrophobic residues are that Hrk expression is also lethal to these cells (data
indicated by bold letters and stars, respectively. References for hBax, not shown).
hBcl-2, hBcl-X, Bik/Nbk, Bak and Mcl-1 proteins are given in the
Introduction.
Hrk requires a region of 16 amino acids containing
BH3 to interact with Bcl-2 and Bcl-XL
To determine the ability of Hrk to associate with Bcl-2 orpattern obtained after transfection with a control Flag-
tagged GATA-1 expression plasmid. Staining of the GATA- Bcl-XL through BH3, we engineered a mutant form of
Hrk lacking BH3. A deletion mutant was designed to1 protein with anti-Flag antibody revealed a nuclear
labeling pattern, as expected for a nuclear transcriptional eliminate residues 34–49 of Hrk, a predicted α-helix, to
minimize secondary effects on folding of the Hrk protein.factor (Figure 5B).
The deleted residues contained the most conserved amino
acids of the BH3 homology region of Hrk (Figures 3CExpression of Hrk induces rapid cell death which is
repressed by Bcl-2 and Bcl-XL and 7A). Expression plasmids producing wild-type or
mutant Flag-tagged Hrk and Bcl-2 or Bcl-XL were transi-The effect of harakiri on cell survival was examined
initially in 293T cells using a transient transfection assay. ently co-transfected into 293T cells. Immunoprecipitates
were prepared using anti-Flag to recognize wild-typeTransfection of a harakiri expression plasmid into 293T
cells resulted in a dramatic loss of cell viability at 36 h and mutant Flag-Hrk and subjected to SDS–PAGE and
immunoblotting using anti-Bcl-2 and anti-Bcl-X anti-post-transfection (Figure 6B and F). This was specific in
that transfection of 293T cells with empty vector, bcl-2 bodies. Deletion of residues 34–49 (Hrk mutant ΔBH3)
completely eliminated the ability of Hrk to interact withor bcl-xL expression plasmids did not have any effect on
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Fig. 5. Flag-Hrk protein is a non-nuclear intracellular protein. 293 cells (5106 cells per 100 mm plate) were transfected with 10 μg of pSFFV-Flag-
Hrk16K (A) or Flag-GATA-1 (B) as a control. Shown are confocal images after labeling with anti-Flag and secondary fluorescein-conjugated
antibody. Samples were prepared at 18 h after transfection. Nuclei and cytoplasm are indicated by N and C, respectively. Notice that cells transfected
with pSFFV-Flag-Hrk16K round up. Scattered bright particles probably represent cellular fragments from dying neighboring cells.
Fig. 6. Expression of Hrk induces cell death which is repressed by Bcl-2 or Bcl- XL. 293T cells (5106 per 100 mm plate) were co-transfected with
20 μg of pSFFV-neo (A and E), 10 μg of pSFFV-Flag-Hrk16K plus 10 μg of pSFFV-neo (B and F), 10 μg of pSFFV-hBcl-2 plus 10 μg of pSFFV-
neo (C), 10 μg of pSFFV-Flag-Hrk16K plus 10 μg of pSFFV-hBcl-2 (D), 10 μg of pSFFV-HA-hBcl-XL and 10 μg of pSFFV-neo (G), 10 μg of
pSFFV-Flag-Hrk16K plus 10 μg of pSFFV-HA-hBcl-XL (H) as described in Figure 2. Photographs represent cells at 36 h after transfection. Notice
that cultures transfected with Flag-harakiri show a paucity of attached live cells and shrunken dead cells (arrows) which are blocked by
co-transfection with bcl-2 or bcl-xL.
Bcl-2 and Bcl-XL (Figure 7B). To confirm these results, In agreement with the reverse experiment, wild-type Hrk
but not mutant Hrk co-immunoprecipitated specificallywe performed reciprocal experiments using anti-Bcl-2
antibody, followed by Western blot with anti-Flag antibody. with Bcl-2 (Figure 7C). Analysis of total lysates from the
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Fig. 7. Hrk requires a region of 16 amino acids containing BH3 to interact with Bcl-2 and Bcl- XL. (A) Schematic structure of wild-type (Flag-Hrk)
and mutant (Flag-Hrk ΔBH3) proteins. (B) 293T cells (5106 per 100 mm plate) were co-transfected with 2 μg of pCDNA3 (CDNA3), pCDNA3-
Flag-Hrk (Hrk) or pCDNA3-Flag-Hrk ΔBH3 (Flag-Hrk ΔBH3) and 10 μg of pSFFV-neo (SFFV), pSFFV-hBcl-2 (Bcl-2) or pSFFV-HA-hBcl-XL
(Bcl-XL) as described in Figure 1. Anti-Flag immunoprecipitates were immunoblotted by anti-Bcl-2 (upper) and anti-Bcl-X antibody (lower).
(C) Anti-Bcl-2 immunoprecipitates were immunoblotted with anti-Flag antibody. (D) Twenty μg of total lysate were immunoblotted with anti-Flag,
anti-Bcl-2 or anti-Bcl-X antibody.
same cellular extracts by immunoblotting confirmed that with mutant Hrk ΔBH3 nor control plasmid displayed
nuclear fragmentation, a cytological change associated293T cells transfected with the corresponding plasmids
expressed Bcl-2, Bcl-XL, wild-type and mutant Hrk pro- with apoptosis (Figure 8B).
teins (Figure 7D).
Discussion
The BH3 domain of Hrk is required for the
induction of cell death We have identified harakiri, a novel regulator of apoptosis
that exhibits death-inducing activity in mammalian cells.To determine if the BH3 domain of Hrk is necessary to
induce cell death, we compared the killing activity of Hrk interacts with Bcl-2 and Bcl-XL, two death-repressing
Bcl-2 family members that play essential roles in main-wild-type and mutant Hrk proteins by a transient transfec-
tion assay in 293T cells. The cells were co-transfected with taining cell survival in embryonic and adult tissues (Veis
et al., 1993; Motoyama et al., 1995). Hrk shares homologya reporter plasmid expressing GFP (green fluorescence
protein), in combination with either an expression plasmid with Bcl-2 in the BH3 domain but, unlike most other
Bcl-2 family members, it lacks conserved BH1 and BH2encoding Hrk proteins or control plasmids. The cell killing
activity of wild-type and mutant Hrk was measured by a regions. The BH3 region appears to represent a critical
domain for interaction with Bcl-2 family members andreduction in the number of cells that express the reporter
GFP protein relative to that obtained by transfection regulation of apoptosis. For example, BH3 is required for
death-promoting Bax and Bak to associate with Bcl-2 andwith a control expression plasmid. The results of these
experiments showed that deletion of residues 34–49 of Bcl-XL (Chittenden et al., 1995a; Han et al., 1996a;
Simonian et al., 1996; Zha et al., 1996). Moreover, deletionHrk (Hrk mutant ΔBH3) dramatically reduced the ability
of Hrk to kill 293T cells, when compared with the activity of BH3 prevented the killing activity of Bak and expression
of a 30 amino acid region of Bak containing BH3 linkedexhibited by wild-type Hrk (Figure 8A). Furthermore,
expression of Bcl-2 or Bcl-XL inhibited the killing activity to a membrane anchor sequence was sufficient for cell
killing activity in transient assays (Chittenden et al.,of wild-type Hrk, confirming the results presented in
Figure 6. The loss of viability and the morphology of the 1995b). In our studies, a 16 amino acid region of Hrk
encompassing BH3 was required for Hrk to interact withcells observed after transfection with Hrk plasmids in
Figure 6 suggested that Hrk may induce apoptotic cell Bcl-2 and Bcl-XL, and its deletion eliminated or greatly
reduced the killing activity of Hrk. In addition, thesedeath. To determine if the cell death activated by transient
Hrk expression was caused by apoptosis, the nuclei of studies demonstrate that a region of 62 residues containing
the BH1 and BH2 regions in Bcl-XL is essential for its293T cells were stained with acridine arange and ethidium
bromide. Cells transfected with wild-type Hrk but not binding to Hrk since Bcl-XS, an alternative form of
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Fig. 8. The BH3 domain of Hrk is required for the induction of cell death. (A) 293T cells (1.7106 per 35 mm plate) were transfected with 0.3 μg
of pRK7.GFP and 0.8 μg of pCDNA3 (control), 0.8 μg of pCDNA3-Flag-Hrk (Hrk) or 0.8 μg of pCDNA3-Flag-Hrk ΔBH3 (ΔBH3) in the presence
or absence of 6.7 μg of pSFFV-neo, pSFFV-hBcl-2 (Bcl-2) or pSFFV-HA-hBcl-XL (Bcl-XL) in triplicate. The number of live cells expressing GFP
was determined at 48 h after transfection by analysis of 5103 cells as described in Materials and methods. The results are shown as the mean of
triplicate values  SD. (B) 293T cells transfected with 0.8 μg of pCDNA3 (vector), pCDNA3-Flag-Hrk (Hrk) and pCDNA3-Flag-Hrk ΔBH3 (Hrk
ΔBH3) were stained at 18 h after transfection with acridine orange and ethidium bromide to stain nuclei. Notice that nuclei of cells transfected with
pCDNA3-Flag-Hrk were condensed and some of them are fragmented (arrows). In the experiment shown, ~20% of the transfected cells exhibited
apoptotic changes in the nuclei.
Bcl-X lacking these conserved domains, failed to associate Oncogenic signals such as deregulated c-Myc or aden-
ovirus E1A can promote or induce apoptosis in cell lineswith Hrk.
Susceptibility of a cell to apoptotic signals appears to (Askew et al., 1991; White et al., 1991; Evan et al.,
1992). Thus, it is conceivable that in tumor cells, apoptoticbe regulated in part by the relative levels and competing
dimerizations of death-suppressing and death-promoting signals are constitutively expressed, although repressed
by Bcl-2 and/or Bcl-XL. Consistent with this is theBcl-2 family members (Oltvai and Korsmeyer, 1994; Sato
et al., 1994). How could Hrk activate cell death? Two observation that expression of Bcl-XS, a functional inhib-
itor of Bcl-2 and Bcl-XL (Boise et al., 1993), activatesnon-exclusive models could be proposed to explain the
role of Hrk in cell death. Hrk could be an effector apoptosis in a wide variety of cancer cells (Clarke et al.,
1995). Thus, physical inactivation of Bcl-2 and Bcl-XLmolecule with intrinsic death-inducing activity, and death-
suppressing Bcl-2 and Bcl-XL may serve as dominant by Hrk could similarly unleash endogenous death signals
leading to execution of the apoptotic program. Thisinhibitors. In support of this model, overexpresssion of
Bcl-2 or Bcl-XL inhibited the killing activity of Hrk. hypothesis is consistent with recent observations in mutant
mice lacking Bcl-2 and Bcl-X (Veis et al., 1993; MotoyamaAlternatively, Hrk could promote cell death by inhibiting
the protective activity of Bcl-2 and Bcl-XL and perhaps et al., 1995). Mice deficient in Bcl-X developed massive
apoptosis of neural and hematopoietic tissues and died atother functional homologs. Inactivation of Bcl-2 and Bcl-
XL would require the interaction of these survival proteins E12–13 of embryonic development (Motoyama et al.,
1995), whereas newly born Bcl-2-deficient mice exhibitedwith Hrk and be mediated by the formation of Bcl-2–Hrk
and/or Bcl-XL–Hrk complexes. The analysis of the Hrk fulminant apoptosis of lymphoid tissues (Veis et al., 1993).
Thus, in addition to cancer cells, expression of Bcl-X orΔBH3 mutant strongly supports the latter model in that a
region of 16 residues containing the BH3 domain required Bcl-2 appears necessary to counter death signals that arise
during normal development. The precise mechanism offor Hrk to interact with Bcl-2/Bcl-XL was also necessary
for Hrk killing activity. However, these studies cannot death triggered by Hrk needs to be determined, but we
hypothesize that it involves the activation of interleukinrule out that Hrk could also act as a death effector
molecule as it is formally possible that the 16 amino acid 1-β converting enzyme-like proteases, a step which appears
to be downstream of Bcl-2 and Bcl-XL in the deathdeletion in Hrk directly or indirectly also affects an
intrinsic death-inducing activity. Similarly, deletion mutant pathway (Chinnaiyan et al., 1996).
harakiri is the second member of a class of cellanalysis of Bak has shown that elimination of BH3 greatly
diminished the killing activity of Bak (Chittenden et al., death regulatory genes that also include bik/nbk. Unlike
‘classical’ bcl-2 family members, the proteins that they1995b). Thus definitive evidence for the second model
will require additional mutational studies and analysis of encode lack conserved BH1, BH2 or BH4 regions but
share the BH3 domain. Our studies indicate that the BH3cells deficient in Hrk.
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Screening of human cDNA library by hybridization withdomain of Hrk is critical for its interaction with Bcl-2 and
labeled probeBcl-XL. Although Hrk and Bik/Nbk share both a BH3 A 9-week human embryo λgt11 cDNA library (Swaroop and Xu, 1993)
domain and a hydrophobic region at the COOH-terminus was screened by hybridization with a 32P-labeled cDNA containing the
predicted to mediate attachment to intracellular mem- entire coding region of harakiri. Approximately 1106 cDNA clones
were screened by standard procedures, and positive phage clones werebranes, these proteins are distinct and do not share
purified by sequential plating and hybridization. DNA inserts wereadditional amino acid homology. Thus, it is possible that
characterized by PCR amplification of phage DNA from purified plaques,
there are subtle differences in the function of Hrk and restriction enzyme mapping of phage DNA inserts and dideoxy
Bik/Nbk. In this respect, it has been shown that Bcl-XS sequencing.
interacts with Bik/Nbk (Boyd et al., 1995), but our analysis
Transfection, immunoprecipitation and Western blotrevealed that Bcl-XS fails to associate with Hrk. In
analysis
addition, Hrk and Bik/Nbk differ in their pattern of
Human embryonic kidney 293T and 293 cells were obtained from Dr
expression in tissues (Boyd et al., 1995), which suggests Vishva Dixit (Department of Pathology, University of Michigan). Culture
dishes containing cells were transfected with the indicated amount (seethat they play distinct roles in the regulation of apoptosis
figure legends) of plasmid DNA by the calcium phosphate method. Thein vivo. Future studies need to address a role for harakiri
expression of Flag-Bcl-XL, Flag-Bcl-2, Flag-Hrk, Flag-Hrk ΔBH3 andin the regulation of physiological cell death during tissue
Bax was determined in total lysates by Western blot analysis as
development and homeostasis. previously described (Merino et al., 1995; Simonian et al., 1996). For
immunoprecipitations, 1107 cells were lysed in NP-40 isotonic lysis
buffer (Oltvai et al., 1993) at 38 h after transfection and the lysates
were rotated with 10 μg/ml of anti-Flag M2 monoclonal antibody
Materials and methods (Scientific Imaging Systems, Rochester, NY), hamster anti-Bcl-2 mono-
clonal antibody (Hockenbery et al., 1991), rabbit anti-Bcl-X (Boise
Screening for Bcl-2-interacting proteins by the yeast et al., 1995) or control Ig overnight at 4°C. Then 5% (v/v) of protein
two-hybrid system
A–Sepharose 4B (Zymed Laboratories Inc., San Francisco, CA) was
A HeLa cDNA library fused to the GAL4 activation domain of the
added for an additional hour of incubation by rotation. Immune complexes
pGAD-GH vector (Hannon et al., 1993) was screened for proteins that were centrifuged and washed with excess cold NP-40 isotonic lysis
interact with human Bcl-2, using the HF7c yeast reporter strain (Feilotter buffer at least four times, separated on a 15% SDS–polyacrylamide gel
et al., 1994). Briefly, the pGAD library plasmid was transformed into and immunoblotted with anti-Bcl-2, anti-Flag, rabbit anti-Bcl-X or
HF7c yeast cells harboring the pGBT-9-bcl-2 bait plasmid by standard control Ig.
transfection procedures. Transformed HF7 cells were plated on medium
lacking tryptophan, leucine and histidine. A total of 3106 library clones Northern blot analysis
were screened for growth in selection medium and assayed for β- A 716 bp harakiri cDNA was radiolabeled by the random priming
galactosidase activity. Positive clones were picked and yeast plasmid method using a commercial kit (Boehringer Mannheim, Indianapolis,
DNA from individual clones was used to transform Escherichia coli IN) and applied for analysis of human multiple tissue blots (Clontech
HB101 (leuB–) cells. Library plasmids were recovered selectively from Laboratories, Palo Alto, CA) according to the manufacturer’s instructions.
bacterial colonies by growth in media lacking leucine. False-positive
clones were eliminated by testing for interaction with empty vector Laser scanning confocal microscopy and fluorescence
pGBT-8 and irrelevant ‘baits’. cDNA inserts in the plasmid were staining of nuclear DNA
characterized by restriction enzyme mapping and nucleotide sequence 293 cells were transfected with pCDNA3-Flag-Hrk, pCDNA3-Flag-
analysis using an automated DNA sequencer (Applied Biosystems GATA-1, or empty vector as described above. Twenty four hours after
Model 373A). transfection, cells were incubated with anti-Flag monoclonal antibody
or control mouse Ig for 1 h at 23°C and the labeling visualized with
fluorescein-conjugated goat anti-mouse IgG. After washing, the cellsPlasmid construction
were mounted in Slowfade (Molecular Probes, Eugene, OR) and exam-Plasmids expressing hBcl-XL or hBcl-XS (Boise et al., 1993), mBax
ined using a BioRad MRC 600 scanning confocal microscope equipped(Oltvai et al., 1993) and hBak (Farrow et al., 1995) in pGBT-9 were
with an argon–xenon laser (González-Garcı́a et al., 1994). Staining ofconstructed by PCR amplification of plasmid cDNA to incorporate
nuclei with acridine orange and ethidium bromide was performed asrestriction sites, followed by ligation of the amplified DNA fragments
described previously (Duke and Cohen, 1994).in-frame with the GAL4 DNA-binding domain of pGBT-9. The authenti-
city of the GAL4 fusion plasmids was confirmed by dideoxy sequencing.
Cell death assaysThe mammalian expression plasmids SFFV-Flag-hBcl-2, SFFV-Flag-
293T, 293 and HeLa cells were co-transfected by a calcium phosphatehBcl-xL and SFFV-Flag-mBax have been described (Merino et al., 1995;
method with pRK7.GFP, a reporter plasmid expressing GFP (a gift ofSimonian et al., 1996). Three different constructs were generated to
Roger Y.Tsien), in combination with an expression plasmid encoding Hrk,express harakiri sequences. In an initial construction, a Flag epitope
Bcl-2, Bcl-XL or control plasmid. The number of plasmids transfected issequence was attached to nucleotide 7 of the 5 untranslated region of
indicated in the figure legends. Killing activity was determined at 48 hthe harakiri cDNA to generate Flag-Hrk16K by PCR using pGAD-GH-
after transfection and based on the analysis of 5103 cells by FACScanharakiri plasmid as a template (see Figure 3A). The Flag sequence in
flow cytometry (Becton Dicknson, Mountain View, CA). In the assay,Hrk16K was in-frame with the amino-terminus of Hrk, resulting in a
the cell killing activity was manifested by a reduction in the number offusion protein with a predicted size of 16 kDa. In a second construction,
cells that express GFP relative to that obtained by transfection with thea Flag-Hrk insert was constructed by introducing a Flag epitope tag at
control expression plasmid.the amino-terminus of Hrk by PCR. A deletion of amino acids 34–49
that includes the BH3 domain of Hrk was generated by a two-step PCR
Accession numbermutagenesis method as described (Simonian et al., 1996). A Flag epitope
The accession number for the nucleotide sequence of harakiri cDNAtag was attached to the amino-terminus of mutated Hrk protein to
reported in this paper is U76376.generate Flag-Hrk ΔBH3. A Flag epitope tag was attached to the amino-
terminus of a control cDNA clone BP25 (N.Inohara, L.Ding and
G.Núñez, unpublished data) by PCR. The Flag-tagged inserts were Acknowledgements
ligated into the EcoRI cloning site of pSFFV-neo or the BamHI and
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